Prof. Dr. Abdulkerim Bedir

Doctor and researcher Medical Park Samsun İstanbul
Kidney Failure, ChronicBreast NeoplasmsHypertensionAmyloidosisUremiaRespiratory Distress Syndrome, NewbornCarcinoma, HepatocellularLiver NeoplasmsColorectal NeoplasmsInsulin ResistanceBehcet SyndromeHepatitis, Viral, HumanDiabetic NephropathiesDiabetes Mellitus, Type 2

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Kidney Failure, Chronic 5 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Breast Neoplasms 4 publications
  • Hypertension 4 publications
  • Amyloidosis 3 publications
  • Uremia 3 publications
  • Respiratory Distress Syndrome, Newborn 2 publications
  • Carcinoma, Hepatocellular 2 publications
  • Liver Neoplasms 2 publications
  • Colorectal Neoplasms 2 publications
  • Insulin Resistance 2 publications
  • Behcet Syndrome 2 publications
  • Hepatitis, Viral, Human 2 publications
  • Diabetic Nephropathies 2 publications
  • Diabetes Mellitus, Type 2 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

  • Klinik biyokimya
  • Moleküler tıp
  • Moleküler genetik
  • Kanser biyokimyası
  • Genotoksikoloji
  • Moleküler tanı yöntemleri

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • Department name at the sourceLaboratuvar Hizmetlerimedicalpark.com.trFrom source
  • InstitutionMedical Park Samsunmedicalpark.com.trFrom source
  • Area of workKidney Failure, ChronicExtracted from 5 publications · Model version —From source
  • Publications104 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-7466-952XORCIDFrom source
  • Last synchronised4 November 2026 20:25https://www.medicalpark.com.tr/hekimler/abdulkerim-bedirmedicalpark.com.tr

Scientific work

Publications on Kidney Failure, Chronic

104 publications
  1. Tracking Cartilage Turnover: Urinary CTX-II as a Biomarker for Early Rheumatoid Arthritis Progression and Anti-TNF Therapy Response

    Eskisehir Medical Journal, Eskisehir City Hospital, 2025

    DOI 10.48176/esmj.2025.201 Open-access full textSource: ORCID

  2. The telomere length of gastric mucosal samples and peripheral blood lymphocytes in patients who have undergone Billroth II distal gastrectomy

    Archives of Medical Science, 2020

    DOI 10.5114/aoms.2020.94656 PMID 32399105 2 citations (Europe PMC) Open-access full textSource: ORCID

  3. Clinical significance of glucocorticoid receptor expression in premature infants with respiratory distress syndrome

    Journal of Maternal-Fetal and Neonatal Medicine, 2017

    DOI 10.1080/14767058.2016.1174992 PMID 27079262 3 citations (Europe PMC) Source: ORCID

  4. Telbivudine attenuates gentamicin-induced kidney injury in rats

    International Journal of Antimicrobial Agents, 2017

    DOI 10.1016/j.ijantimicag.2017.01.015 PMID 28373116 6 citations (Europe PMC) Source: ORCID

  5. In vitro cytotoxic effect of water extracts of Turkish propolis on human laryngeal epidermoid carcinoma cell line

    The FEBS Journal, 2016

    Source: ORCID

  6. Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and NDRG1 genes

    Tumor Biology, 2016

    DOI 10.1007/s13277-015-4119-2 PMID 26419593 15 citations (Europe PMC) Source: ORCID

  7. Assessment of different folic acid supplementation doses for low-birth-weight infants,Düşük doğum ağırlıklı bebeklere verilen farklı folik asit destek dozlarının değerlendirilmesi

    Turk Pediatri Arsivi, 2016

    DOI 10.5152/turkpediatriars.2016.4235 PMID 28123334 4 citations (Europe PMC) Open-access full textSource: ORCID

  8. Is Serum Caveolin-1 a Useful Biomarker for Progression in Patients with Colorectal Cancer?

    Clinical Laboratory, 2016

    DOI 10.7754/clin.lab.2015.150719 PMID 27156330 10 citations (Europe PMC) Source: ORCID

  9. Is there any role of epithelial to mesenchymal transition in the pathogenesis of contrast nephropathy?

    Renal Failure, 2016

    DOI 10.1080/0886022x.2016.1209381 PMID 27435174 3 citations (Europe PMC) Open-access full textSource: ORCID

  10. MP026IS THERE ANY ROLE OF EPITHELIAL TO MESENCHYMAL TRANSITION IN THE PATHOGENESIS OF CONTRASTNEPHROPATHY?

    Nephrology Dialysis Transplantation, 2016

    DOI 10.1093/ndt/gfw181.26 Source: OpenAlex

View all 104 publications